Marc Iskowitz

Ruiz returns to Havas from Deloitte Digital, while Skelly arrives from Edelman.

The smaller budgets and tactical pull-through seen in the MM+M/Swoop Healthcare Marketers Trend Report reflect marketers' greater focus on achieving optimization, rather than sheer scale.

As advertisers pay more for an ever-scarcer supply of ratings points, pharma’s ironclad devotion to TV could finally be in jeopardy

2 senators asked FDA to review the ad, which has also elicited ample criticism from patient groups.

Following last month’s fatal shooting of an insurance executive, healthcare’s largest investor meeting has assumed a higher security posture.

Here are 5 tips designed to help pharma marketers set a tone for their messaging this year, as suggested by a group of their peers.

Data suggest a move away from compensation as the be-all and end-all for medical marketers. Is thriving at work the ‘new black’?

While they’ve been down this road before, many in pharma are taking his threat to ban DTC drug advertising seriously.

Set to become compulsory Nov. 20, the regulation isn't likely to make pharma ads easier for consumers to comprehend, but should aid in drugmakers’ ability to meet the fair-balance standard.

The second annual survey shows pharma is making progress, but still has a long way to go to digitally enable the marketing function.